Comirnaty®/Spikevax®
COVID-19 mRNA Vaccine
Version 2025-04 · Last reviewed April 1, 2025 · Methodology
List Price
$30-130 per dose (government pricing)
With Insurance
$0
How It Works
mRNA vaccines (Pfizer/Moderna) deliver instructions to your cells to produce the SARS-CoV-2 spike protein. Your immune system learns to recognize this protein and mounts a response — without any live virus. The mRNA itself degrades within days.
Why the side effects happen
Second-dose reactions are stronger because the immune system is seeing the spike protein for the second time — a stronger, faster response. The mRNA is encapsulated in lipid nanoparticles that are injected into muscle, explaining the arm soreness and local inflammation.
When Will I Feel It?
Initial protection 2 weeks after first dose. Full primary series protection 2 weeks after second dose. Boosters extend and broaden immunity.
Partial protection begins. First immune response established.
Full primary series protection against severe disease.
Updated boosters target current variants. Annual COVID vaccination is recommended similarly to flu.
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Common Side Effects
While taking this medication, you may experience the following common side effects. We've included tips on how to manage them.
Injection site pain / redness / swelling
80-90%Apply ice after injection; more common with 2nd dose
Fatigue
60-70%Rest for 24-48 hours; very common especially with 2nd dose
Headache
50-60%OTC pain relievers help; usually resolves within 24-48 hours
Muscle aches / chills
35-60%Normal systemic immune response; acetaminophen can help
Fever (low-grade)
10-20%Normal and expected; indicates immune response; 1-3 days
Nausea
15-25%Usually mild; eat before vaccination and stay hydrated
Swollen lymph nodes in armpit
10-15%Normal immune response; can last 10-14 days; can affect mammogram
Arm swelling / redness beyond injection site
10%"COVID arm" — can appear days later; apply corticosteroid cream; not dangerous
Joint pain
8%Usually 1-2 days; NSAIDs or acetaminophen help
Diarrhea
5-10%Usually mild and brief; stay hydrated
Serious Adverse Effects
- • Myocarditis/pericarditis (especially males 16-30, after 2nd dose): ~1-5 per 10,000
- • Anaphylaxis: ~2-5 per million doses
- • Rare blood clotting disorders (mRNA vaccines: very rare)
- • Bell's palsy: slightly elevated risk (rare)
- • Pericarditis in older adults (rare)
Drug Interactions
Moderate Interactions (Caution)
When to Contact Your Doctor
This medication requires ongoing medical supervision. The following situations warrant a prompt conversation with your prescribing physician — do not wait for your next scheduled appointment.
Contact soon if you notice
- Myocarditis/pericarditis (especially males 16-30, after 2nd dose): ~1-5 per 10,000
- Anaphylaxis: ~2-5 per million doses
- Rare blood clotting disorders (mRNA vaccines: very rare)
- Bell's palsy: slightly elevated risk (rare)
Also discuss if you want to
- Review whether this medication is still appropriate for you
- Consider dosage adjustments based on response
- Explore lifestyle or non-drug alternatives
- Understand stopping or tapering options
- Plan monitoring labs and follow-up
In the US, call 911 or go to the nearest emergency room for severe symptoms. Poison Control: 1-800-222-1222.
FDA Adverse Event Reports
Patient-filed reports from the FDA FAERS database · refreshed daily
Community Reports
User-reported experiences — anonymous & anecdotal
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Metabolic & Lifestyle Alternatives
Lifestyle & Metabolic Factors in COVID Resilience
Metabolic health is associated with significantly reduced COVID-19 severity across multiple large cohort studies
Important context: Evidence quality varies across these approaches. Some are well-studied with randomized controlled trial data; others are based on observational or smaller studies. These interventions are not guaranteed to replace medication for all patients. Discuss with your doctor whether any of these are appropriate for your clinical situation.
Vitamin D (2000-5000 IU)
Target 50-80 ng/mL
Low vitamin D strongly linked to severe COVID outcomes
Zinc (15-30mg)
At first symptoms
Reduces viral replication; antiviral properties
Weight/BMI normalization
Healthy BMI 18.5-24.9
Obesity = 3-4x risk of severe COVID; #1 modifiable risk
Blood sugar control
HbA1c <7% for diabetics
Diabetes with poor glycemic control = highest COVID risk group
Global Prescribing & Pricing
COVID-19 vaccination completion varied approximately 2× across G7 nations, reflecting differences in delivery infrastructure, access, and public trust
United States
Free (federally funded until 2023; ~$30–190 now uninsured)/mo
72% initial series completion — fell significantly over time
Voluntary; mandates created significant controversy and legal challenges
Covered by most insurance; federally funded ended 2023
United Kingdom
Free (NHS)/mo
78% completion — highest G7; now annual for 75+, high-risk
NHS digital recall system sent personalized outreach to every eligible adult; community vaccination hubs
Free — NHS funded
Australia
Free/mo
95% of adults 16+ received 2 doses — highest developed-world completion
State-by-state rollout with sector mandates; aggressive GP and pharmacy delivery
Free — national funding
Japan
Free/mo
83% completion — efficient infrastructure delivery
Existing public health infrastructure used efficiently; high social trust; now annual for high-risk only
Free — national funding
Sweden
Free/mo
~75% completion — targeted risk-stratified approach
Annual booster for 65+; healthy young adults not recommended for further boosters
Free for eligible groups
Australia achieved 95% adult COVID vaccination — the world's highest — using state mandates in healthcare and aged care combined with aggressive GP delivery. The UK's NHS digital recall system achieved 78% by personalizing outreach to every eligible adult. The US achieved 72% without a national recall infrastructure.
Clinical Trials & Funding
Understanding who funds research helps contextualize results. Industry-funded trials are not automatically invalid — they undergo the same FDA review — but declared conflicts and sponsor effects are worth knowing. All linked trials can be verified on ClinicalTrials.gov.
Funding Sources
Registration trials were manufacturer-funded under Emergency Use Authorization, based on approximately 2-month follow-up data. Post-marketing surveillance (CDC VSD, VAERS) identified higher-than-expected myocarditis rates in males aged 12–39 (estimated 11–22 cases per 100,000 doses); risk remains lower than myocarditis risk from COVID-19 infection itself.
Declared Conflicts of Interest
FDA revolving door: multiple officials left for pharmaceutical industry positions. ACIP members with Pfizer and Moderna financial ties voted on recommendations. Pfizer and Moderna received $30B+ in government contracts. Independent safety signals initially minimized.
Key Efficacy Results
Original 95% efficacy against original Omicron; reduced significantly against Omicron variants
Referenced Studies
Each study carries a Cochrane RoB-2 risk-of-bias badge — tap the badge for details.
Evidence & Transparency
Cochrane RoB-2 (Risk of Bias)
Badges reflect an editorial assessment using Cochrane's RoB-2 tool domains: randomization, intervention deviation, missing data, outcome measurement, and selective reporting. These are not certified Cochrane reviews. Learn more ↗
CMS Open Payments
Manufacturer payment disclosures are reported via the CMS Sunshine Act. Disclosure is legally required and does not imply bias or misconduct. Language uses "may," "suggests," or "appears" — never definitive clinical claims. CMS Open Payments ↗
Live Clinical Trials
Live from ClinicalTrials.gov · refreshed every 4 hours
Currently enrolling, active, and recently completed studies involving COVID-19 mRNA Vaccine. Data is pulled directly from the U.S. National Library of Medicine.
Recent Research
Live from PubMed · peer-reviewed literature · refreshed every 4 hours
Most recently indexed clinical trials and systematic reviews mentioning COVID-19 mRNA Vaccine in PubMed.
Source Documentation
Structured citations for referenced clinical trials
Each referenced trial is listed with its registry ID, funding source, and bias assessment. Use the copy button to generate a formatted citation.
| Trial | Registry ID | Cite |
|---|---|---|
| Pfizer C4591001 | NCT04368728 | |
| Moderna mRNA-1273 | NCT04470427 |
Bias ratings use Cochrane RoB-2 methodology. Editorial assessment — not a certified Cochrane review.
Our MethodologyMedical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Stopping This Medication Safely
COVID vaccines are given as a primary series plus annual updated boosters — there is no tapering involved. Annual boosters are recommended to maintain protection against circulating variants.
Never change or stop a medication without consulting your prescribing physician.
Questions for Your Doctor
Questions to Ask
- 1.Am I in a high-risk group that benefits most?
- 2.Which updated formulation is recommended?
- 3.What should I watch for after vaccination?
- 4.Is my vitamin D level adequate?
Lab Tests to Request
- Vitamin D level
- Blood glucose / HbA1c
- BMI assessment
- Immunocompromised status
Medical Disclaimer
The information on this page is compiled from publicly available clinical trial data, FDA prescribing information, and peer-reviewed literature. It is provided for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual responses to medications vary. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.
Frequently Asked Questions About Comirnaty®/Spikevax®
- What is Comirnaty®/Spikevax® used for?
- Comirnaty®/Spikevax® (COVID-19 mRNA Vaccine) is a Vaccine (mRNA) manufactured by Pfizer-BioNTech / Moderna. FDA-approved indications include: COVID-19 prevention; Severe disease risk reduction.
- What are the common side effects of Comirnaty®/Spikevax®?
- Common side effects of Comirnaty®/Spikevax® include: Injection site pain / redness / swelling (80-90%); Fatigue (60-70%); Headache (50-60%); Muscle aches / chills (35-60%); Fever (low-grade) (10-20%).
- How much does Comirnaty®/Spikevax® cost?
- Comirnaty®/Spikevax® list price is approximately $30-130 per dose (government pricing). With insurance it typically costs $0; without insurance approximately $100-200 (if uninsured).
- Who funded the clinical trials for Comirnaty®/Spikevax®?
- Registration trials were manufacturer-funded under Emergency Use Authorization, based on approximately 2-month follow-up data. Post-marketing surveillance (CDC VSD, VAERS) identified higher-than-expected myocarditis rates in males aged 12–39 (estimated 11–22 cases per 100,000 doses); risk remains lower than myocarditis risk from COVID-19 infection itself.
- How strong is the clinical evidence for Comirnaty®/Spikevax®?
- Key studies: C4591001 (Pfizer), mRNA-1273-P301 (Moderna). Original 95% efficacy against original Omicron; reduced significantly against Omicron variants Potential conflicts of interest: FDA revolving door: multiple officials left for pharmaceutical industry positions. ACIP members with Pfizer and Moderna financial ties voted on recommendations. Pfizer and Moderna received $30B+ in go.
- Are there non-drug alternatives to Comirnaty®/Spikevax®?
- Metabolic health is associated with significantly reduced COVID-19 severity across multiple large cohort studies See the Alternatives tab for full details.
Get notified when we update Comirnaty®/Spikevax®
We'll email you when new evidence, safety updates, or alternatives are added.
No spam. Unsubscribe anytime.